The Misalignment of Clinical Development and Field Medical Affairs

clinical development, field medical affairs, MSLs recruitment, pharmaceutical strategies, Boehringer Ingelheim

In this episode, Tom Caravela is joined by Carrie Caretta and Giancarlo Maranzano from Boehringer Ingelheim to explore the integration of clinical development and field medical affairs. They discuss the strategic role of field medical teams in clinical trial recruitment and how MSLs can effecti…

Mar 22^nd • 29 mins listen

Is it Ever Too Early or Too Late

Medical Science Liaison, drug development, early MSL engagement, clinical trial planning, strategic prioritization

In this episode, Tom Caravela is joined by Jeff Vaughn and Dean McAllister to discuss the critical timing of Medical Science Liaison (MSL) involvement in drug development. They explore misconceptions and historical approaches, highlighting the impact and internal value of early MSL engagement. The c…

Feb 18^th • 34 mins listen

Oncology Clinical Trials and Drug Development

ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug…

Oct 16^th • 38 mins listen